Skip to main content
CYTK logo
CYTK
(NASDAQ)
Cytokinetics, Incorporated
$66.73-- (--)
Loading... - Market loading

Cytokinetics, Incorporated (CYTK) Analyst Forecast

Analyst consensus ratings, 12-month price targets, and expert recommendations for Cytokinetics, Incorporated stock.

Analyst Consensus Rating

Investment consensus from 20 professional research analysts

Consensus Rating

Buy
Based on 20 unique analysts
(24 total ratings in last 90 days)
Very High Confidence:1 Buy/Sell

Average Price Target

$82.68
23.90% Upside

Loading chart...

Strong Sell
Sell
Hold
Buy
Strong Buy

Latest CYTK Analyst Ratings & Recommendations

Recent analyst recommendations with rating changes and price target updates (last 90 days)

Salim Syed
Mizuho
BuyMaintains
$84.00 $100.00
Tessa Romero
JP Morgan
BuyMaintains
$74.00 $75.00
Yasmeen Rahimi
Piper Sandler
BuyMaintains
$107.00
Ashwani Verma
UBS
HoldMaintains
$61.00 $69.00
Leonid Timashev
RBC Capital
BuyMaintains
$101.00
Google Biotechnology
TipRanks - Google
HoldReiterates
$64.00 $68.00
PerPlexity Biotechnology
TipRanks - PerPlexity
HoldReiterates
$66.00 $63.00
Anthropic Biotechnology
TipRanks - Anthropic
HoldReiterates
$66.00 $62.00
DeepSeek Biotechnology
TipRanks - DeepSeek
HoldReiterates
$63.00
xAi Biotechnology
TipRanks - xAI
HoldReiterates
$62.00
OpenAI Biotechnology
TipRanks - OpenAI
HoldReiterates
$65.00 $63.00
Roanna Ruiz
Leerink Partners
BuyMaintains
$83.00 $84.00
Jason Butler
Citizens
BuyMaintains
$88.00 $96.00
Jason Butler
Citizens JMP
BuyMaintains
$88.00 $96.00
Carter Gould
Cantor Fitzgerald
BuyMaintains
-
Serge Belanger
Needham
Strong BuyMaintains
$84.00 $85.00
Maxwell Skor
Morgan Stanley
BuyMaintains
$90.00
Leonid Timashev
RBC Capital
BuyMaintains
$95.00 $101.00
Srikripa Devarakonda
Truist
Strong BuyMaintains
$84.00 $92.00
Gena Wang
Barclays
BuyInitiates
$87.00
Mayank Mamtani
B Riley
Strong BuyMaintains
$90.00 $108.00
Leonid Timashev
RBC Capital
BuyReiterates
$95.00 $95.00
Tessa Romero
JP Morgan
BuyMaintains
$70.00 $74.00
Roanna Ruiz
Leerink Partners
BuyReiterates
-

Frequently Asked Questions

What is the analyst consensus rating for CYTK?

The analyst consensus rating for CYTK is "Buy" based on 20 analyst recommendations.

What is the average price target for CYTK?

The average 12-month price target for CYTK is $82.68, representing an upside of 23.9% from the current price of $66.73.

What do analyst ratings mean?

Analyst ratings indicate investment recommendations: Strong Buy and Buy are bullish signals suggesting the stock may outperform. Hold means the stock is fairly valued. Sell and Strong Sell are bearish signals suggesting potential underperformance. These ratings are based on fundamental analysis and valuation models.

What is a price target?

A price target is an analyst's projection of a stock's fair value over a specific timeframe, typically 12 months. Analysts use fundamental analysis, financial modeling, and industry comparisons to estimate where the stock should trade. Price targets can range from low (conservative) to high (optimistic) estimates.